LC
ZYME icon

Lindbrook Capital’s Zymeworks ZYME Stock Holding History

Lindbrook Capital’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$4.42K Hold
371
– – ﹤0.01% 1997
2024
Q4 		$5.43K Hold
371
– – ﹤0.01% 1945
2024
Q3 		$4.66K Hold
371
– – ﹤0.01% 2040
2024
Q2 		$3.16K Buy
371
+53
+17% +$472 ﹤0.01% 2196
2024
Q1 		$3.35K Hold
318
– – ﹤0.01% 2064
2023
Q4 		$3.3K Buy
+318
New +$2.53K ﹤0.01% 2081
2023
Q3 		– Sell
-35
Closed -$302 – 2842
2023
Q2 		$302 Buy
+35
New +$313 ﹤0.01% 2614

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Lindbrook Capital's ZYME Position: Q1 2025 in Review

Lindbrook Capital held its Zymeworks (ZYME) position steady in Q1 2025 at 371 shares worth $4.42K. The position accounts for ﹤0.01% of the portfolio, ranked #1997.

Lindbrook Capital first reported a position in ZYME in Q2 2023 and has held it in 7 quarters since. The position peaked at $5.43K in Q4 2024. 184 funds tracked by Wall St. Rank hold ZYME as of Q1 2025.

  • Lindbrook Capital held 371 shares of Zymeworks worth $4.42K as of Q1 2025.
  • Lindbrook Capital left its Zymeworks share count unchanged in Q1 2025.
  • Zymeworks made up ﹤0.01% of Lindbrook Capital's portfolio in Q1 2025, its #1997 holding.
  • Lindbrook Capital first reported a position in Zymeworks in Q2 2023 and has held it in 7 quarters since.
  • Lindbrook Capital's Zymeworks position peaked at $5.43K in Q4 2024.
  • 184 funds tracked by Wall St. Rank held Zymeworks as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.